1. Main page
  2. Biotechnology
  3. Silence Therapeutics

Silence Therapeutics

6 Decision Makers · 8 Verified Contacts & Email Format

silence-therapeutics.com
📍 London, England, United KingdomBiotechnology🗓 Est. 1999👥 101–250 employees

About Silence Therapeutics

Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.

Email Format

{first_letter_first_name}.{last_name}@silence-therapeutics.com — 100.0%

s.smith@silence-therapeutics.com

Leadership & Decision Makers

Contact details of 6 Silence Therapeutics decision makers

Rhonda Hellums

Chief Financial Officer LinkedIn

  • Work email

    r*******s@silence-therapeutics.com

Dmitry Samarsky

Chief Scientific Officer

Craig Tooman

President and Chief Executive Officer

John Paul Gabriel

Chief Technical Operations Officer and Senior Vice President

John Strafford

SVP, Head of Business Development, Alliance Management and New Product Development

Stephen Parker

Director

Team & Specialists

Contact details of 2 Silence Therapeutics team members

Steve Romano

Chief Medical Officer and Head of Research and Development,Non Executive Director

Adrien Weingärtner

Group Leader Drug Delivery

General Emails

General company emails, e.g. customer support lines

    info@silence-therapeutics.com

    General Inquiries

    IR@silence-therapeutics.com

    Investor Relations

    a.mortazavi@silence-therapeutics.com

    Unclassified inbox

    u003eir@silence-therapeutics.com

    Investor Relations

    nir@silence-therapeutics.com

    Investor Relations

Verify Silence Therapeutics Emails

Similar Companies like Silence Therapeutics

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

GlaxoSmithKline

gsk.com
Biotechnology · London, England, United Kingdom · Est. 1929 · Above 10001 employees

HQ: London, England, United Kingdom

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

silence-therapeutics.com

+4402037009711

London, England, United Kingdom

Specialization: Therapeutics,
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: 1999
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:SLN
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +4402037009711
Last Investment Activity: Mar 13, 2024
Investments Activity: Mar 13, 2024 Mar 13, 2024 Feb 27, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.